|
|
Investment opportunities From time to time investment
opportunities may be available to support capitalization needs of this growing practice and the pursuit of the patent for
our novel cancer treatment method involving combined use of an interferon and a statin. When investment products are
offered, very favorable terms are extended to investors. Investment is not always open and no public offering is made.
Interested investors are always welcomed to request full details by addressing written correspondence to: Stephen B. Cantrell, MD NeoPlas Innovation 6 Cadillac Drive Suite 110 Brentwood, TN 37027 We would appreciate receiving serious inquiries only. Several investment products may be available with varying
degrees of risk and return potential. The minimum investment amount is $10,000 USD for a product offering excellent
return potential and a no-loss guarantee, and $40,000 for a product with no limit on return and no guarantee against loss.
Individuals, investor groups, and institutions may be considered. International investors may be considered if able
to conduct transactions in the United States. All transactions are subject to applicable law including taxation of income
realized. Please note that anonymous inquiries or those arriving by e-mail will not be honored.
|
|